Provenance du réseau au premier degré de Eric Yuen
Entité | Type d'entité | Industrie | |
---|---|---|---|
Asceneuron SA
Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland.
14
| Holding Company | Pharmaceuticals: Major | 14 |
Spirovant Sciences, Inc.
Spirovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Spirovant Sciences, Inc. is a gene therapy company, which engages in the development of gene therapies for cystic fibrosis and other lung diseases. It offers AAV platform which consists of a highly optimized transgene payload, a novel AAV capsid, and an augmenter; and lentiviral platform, a pseudotyped with an envelope protein which has demonstrated capability to transduce human airway epithelia from apical surfaces. Its pipeline include SPIRO-2101, SPIRO-2102, and SPIRO 2110. The company was founded by Joan Lau and Eric Yuen and is headquartered in Philadelphia, PA.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Eric Yuen via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
MORGAN STANLEY | Investment Managers | Corporate Officer/Principal | |
UNIVERSAL DISPLAY CORPORATION | Electronic Production Equipment | Director/Board Member | |
ROCKWELL MEDICAL, INC. | Medical Specialties | Director/Board Member | |
Brandywine Operating Partnership LP
Brandywine Operating Partnership LP Real Estate Investment TrustsFinance Brandywine Operating Partnership LP provides leasing, property management, development, redevelopment, maintenance services, tenant service, acquisition, and other tenant-related services for a portfolio of office, industrial, retail and mixed-use properties. The company operates through the following segments: Philadelphia Central Business District (Philadelphia CBD); Pennsylvania Suburbs; Metropolitan Washington, DC; Austin, Texas; and Other. The company was founded in 1996 and is headquartered in Philadelphia, PA. | Real Estate Investment Trusts | Director/Board Member | |
IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Generic | Director/Board Member | |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
OXFORD BIOMEDICA PLC | Biotechnology | Director/Board Member | |
GREENHILL & CO., INC. | Investment Banks/Brokers | Corporate Officer/Principal | |
Dr. Reddy's Research & Development BV
Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
Longbow Capital Partners LP
Longbow Capital Partners LP Investment ManagersFinance Longbow Capital Partners LP (Longbow) is an independent hedge fund manager headquartered in New York City. The firm was founded by Thomas Fitzgerald III and Douglas Snyder in 2003. Longbow provides investment advice to high net worth individuals. | Investment Managers | Corporate Officer/Principal | |
University of London | College/University | Doctorate Degree Doctorate Degree | |
Yale University | College/University | Graduate Degree | |
INNATE PHARMA | Pharmaceuticals: Major | Corporate Officer/Principal | |
ABLYNX | Biotechnology | Director/Board Member | |
ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member | |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
École normale supérieure Paris-Saclay | College/University | Undergraduate Degree | |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
TopiVert Ltd.
TopiVert Ltd. BiotechnologyHealth Technology TopiVert Ltd. develops topical treatments for inflammatory diseases of the eye and gut. Its application is used in the treatment of asthma, chronic obstructive pulmonary disease, and cystic fibrosis and other inflammatory diseases of the lungs. The company was founded by Eric Charles Meldrum in 2011 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
STJ Advisors LLP
STJ Advisors LLP Investment ManagersFinance STJ Advisors LLP provides capital markets advisory services. The private company is based in London, UK and has subsidiaries in Hong Kong. The British company was founded in 2008 by John James Moore St. John. | Investment Managers | Corporate Officer/Principal | |
SAFE ORTHOPAEDICS SA | Medical Specialties | Director/Board Member | |
St Peters College Oxford | College/University | Graduate Degree | |
BIOTALYS NV | Chemicals: Agricultural | Director/Board Member | |
MedDay Pharmaceuticals SAS
MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Biotechnology | Chief Executive Officer | |
Progenitor Labs Ltd.
Progenitor Labs Ltd. Pharmaceuticals: MajorHealth Technology Progenitor Labs Ltd. develops drugs to regenerate specific tissues of the human body in response to injury, disease, and ageing. Its products include ProScreen and CombiCult. The company was founded by Yen Choo on February 12, 2010 and is headquartered in Stevenage, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Pulmocide Ltd.
Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Puridify Ltd.
Puridify Ltd. Miscellaneous Commercial ServicesCommercial Services Puridify Ltd. develops bioprocessing technologies. It develops a platform purification technology that will improve processing opportunities and reduce costs. The company was founded by Oliver Hardick, Iwan Thomas Roberts and Thomas Edward Haywood in 2013 and is headquartered in Stevenage, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
DECIBEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
CMR Surgical Ltd.
CMR Surgical Ltd. Medical SpecialtiesHealth Technology CMR Surgical Ltd. develops universal robotic system for minimal access surgery. The firm is presently evaluating the ability of the versius system to perform upper GI, gynaecological, colorectal and renal surgery in cadaveric trials. The company was founded by Martin Frost and Mark Slack in January 2014 and is headquartered in Cambridge, the United Kingdom. | Medical Specialties | Director/Board Member | |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
Creabilis SA | Director/Board Member | ||
GENKYOTEX SA. | Pharmaceuticals: Major | Director/Board Member | |
DNA Script SAS
DNA Script SAS Medical SpecialtiesHealth Technology DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Pharmaceuticals: Major | Director/Board Member | |
Comet Therapeutics, Inc.
Comet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Comet Therapeutics, Inc. develops and commercializes treatments for patients suffering from metabolic, neurological and immunological disorders. The company was founded by Angellina Sekirnik and Enej Kuscer in 2008 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One Capital Management LP (SR One) is a venture capital firm founded in 2020. The firm is headquartered in Redwood, California. | Investment Managers | Consultant / Advisor Corporate Officer/Principal | |
Noema Pharma AG
Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Arnout Ploos van Amstel, Jorge Santos da Silva, Kristian Reich. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Pharmaceuticals: Major | Director/Board Member | |
MOONLAKE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
Etats-Unis | 16 |
Royaume-Uni | 14 |
France | 9 |
Suisse | 5 |
Belgique | 4 |
Sectorielle
Health Technology | 35 |
Finance | 9 |
Consumer Services | 5 |
Electronic Technology | 2 |
Process Industries | 2 |
Opérationnelle
Director/Board Member | 115 |
Independent Dir/Board Member | 25 |
Corporate Officer/Principal | 21 |
Chairman | 20 |
Private Equity Investor | 13 |
Relations les plus connectées
Insiders | |
---|---|
Catherine Moukheibir | 29 |
Deborah Harland | 27 |
Henrijette Richter | 21 |
Jeanne Bolger | 20 |
Joan Lau | 19 |
Hakan Goker | 18 |
Peter van Vlasselaer | 15 |
Matthew Foy | 13 |
Vanessa Malier | 10 |
Barbara Angehrn Pavik | 6 |
Ryan Schubert | 5 |
Dirk Beher | 3 |
Christoph Wiessner | 1 |
Christian Haass | 1 |
Adam Boxer | 1 |